Figure 2.

Change in C-reactive protein (CRP) concentration (left) and erythrocyte sedimentation rate (ESR; right) before and after infliximab and plant-based diet as first-line (IPF) therapy in 13 patients with severe ulcerative colitis who achieved clinical remission. Solid bar denotes mean, and error bar shows standard deviation. Arrows with a number in parentheses indicate 3 infliximab infusions at weeks 0, 2, and 6. CRP concentrations and ESRs are presented in Table 3. CRP concentrations and ESRs after IPF therapy were significantly decreased compared with before therapy (analysis of variance, p < 0.0001).